Filed Pursuant to Rule 424(b)(3)
Registration No. 333-102259
TEVA PHARMACEUTICAL FINANCE B.V.
TEVA PHARMACEUTICALS INDUSTRIES LIMITED
SUPPLEMENT NO. 1
DATED APRIL 11, 2003
TO
PROSPECTUS
DATED MARCH 21, 2003
This supplement is part of and should be read in conjunction with our
prospectus dated April 21,2003. The information we present in this supplement
supersedes similar information included in the prospectus.
We are supplementing the information under the caption "Selling
Securityholders" to include new Selling Securityholders and the number of
Debentures and ADRs owned and offered thereby:
Principal
Amount of
Debentures
ADRs Beneficially Owned and
Owned Offered ADRs
Before Offering Hereby Offered ADRs Beneficially Owned
Name and Address of Selling Securityholder (1)(2) (in $1,000s) Hereby (1) After Offering (2)
-------------------------------------------- ------------------- ----------- ---------- -----------------------
Percentage Percentage
Amount (3) Amount (3)
------- ---------- ----------- ---------- -------- ----------
Advisory Convertible Arbitrage Fund (I) L.P. 23,311 * 1,000 23,311 0 N/A
(5)
c/o General Counsel's Office, American
Express Financial Advisors Inc.
50592 AXP Financial Center
Minneapolis, MN 55474
AM Investment D Fund I, LP
c/o AM Investment Partners 27,973 * 1,200 27,973 0 N/A
350 Park Avenue, 4th Floor
New York, NY 10022
----------
* Less than 1%
(1) Assumes conversion of all of the selling securityholder's debentures at a conversion rate of 23.3106 ADRs per each
$1,000 principal amount of debentures (rounded down to the nearest whole ADR).
(2) Includes, if applicable, conversion of all the selling securityholder's Teva Pharmaceutical Finance, LLC 1.50%
Convertible Senior Debentures due 2005 at a conversion rate of 23.1934 ADRs per each $1,000 principal amount of
debentures (rounded down to the nearest whole ADR). Includes, if applicable, conversion of all the selling
securityholder's Teva Pharmaceutical Finance, LLC 0.75% Convertible Senior Debentures due 2021 at a conversion rate of
23.3036 ADRs per each $1,000 principal amount of debentures (rounded down to the nearest whole ADR).
(3) Assumes that debentures held by other holders are not converted.
(4) The selling securityholder is a broker-dealer.
(5) The selling securityholder is an affiliate of a broker-dealer.
Principal
Amount of
Debentures
ADRs Beneficially Owned and
Owned Offered ADRs
Before Offering Hereby Offered ADRs Beneficially Owned
Name and Address of Selling Securityholder (1)(2) (in $1,000s) Hereby (1) After Offering (2)
-------------------------------------------- ------------------- ----------- ---------- -----------------------
Percentage Percentage
Amount (3) Amount (3)
------- ---------- ----------- ---------- -------- ----------
AM Investment E Fund, LP
c/o AM Investment Partners 132,870 * 5,700 132,870 0 N/A
350 Park Avenue, 4th Floor
New York, NY 10022
Arkansas Teachers Retirement
c/o Nicholas Appelgate 77,741 * 3,335 77,741 0 N/A
600 West Broadway, 32nd Floor
San Diego, CA 92101
Baptist Health of South Florida
c/o Nicholas Appelgate 14,919 * 640 14,919 0 N/A
600 West Broadway, 32nd Floor
San Diego, CA 92101
CALAMOS Convertible Fund - CALAMOS
Investment Trust 201,443 * 7,000 201,443 38,269 *
c/o CALAMOS Investments
1111 East Warrenville Road
Naperville, IL 60563-1493
Canyon Capital Arbitrage Master Fund, Ltd.
(5) 153,836 * 4,650 153,836 45,442 *
c/o Canyon Capital Advisors LLC
9665 Wilshire Blvd., Ste. 200
Beverly Hills, CA 90212
Canyon Value Realization Fund (Cayman), Ltd
(5) 230,754 * 6,975 230,754 68,163 *
c/o Canyon Capital Advisors LLC
9665 Wilshire Blvd., Ste. 200
Beverly Hills, CA 90212
Canyon Value Realization Fund, L.P. (5)
c/o Canyon Capital Advisors LLC 102,558 * 3,100 102,558 30,295 *
9665 Wilshire Blvd., Ste. 200
Beverly Hills, CA 90212
Canyon Value Realization MAC 18, LTD (RMF)
(5) 25,640 * 775 25,640 7,574 *
c/o Canyon Capital Advisors LLC
9665 Wilshire Blvd., Ste. 200
Beverly Hills, CA 90212
----------
* Less than 1%
(1) Assumes conversion of all of the selling securityholder's debentures at a conversion rate of 23.3106 ADRs per each
$1,000 principal amount of debentures (rounded down to the nearest whole ADR).
(2) Includes, if applicable, conversion of all the selling securityholder's Teva Pharmaceutical Finance, LLC 1.50%
Convertible Senior Debentures due 2005 at a conversion rate of 23.1934 ADRs per each $1,000 principal amount of
debentures (rounded down to the nearest whole ADR). Includes, if applicable, conversion of all the selling
securityholder's Teva Pharmaceutical Finance, LLC 0.75% Convertible Senior Debentures due 2021 at a conversion rate of
23.3036 ADRs per each $1,000 principal amount of debentures (rounded down to the nearest whole ADR).
(3) Assumes that debentures held by other holders are not converted.
(4) The selling securityholder is a broker-dealer.
(5) The selling securityholder is an affiliate of a broker-dealer.
-2-
Principal
Amount of
Debentures
ADRs Beneficially Owned and
Owned Offered ADRs
Before Offering Hereby Offered ADRs Beneficially Owned
Name and Address of Selling Securityholder (1)(2) (in $1,000s) Hereby (1) After Offering (2)
-------------------------------------------- ------------------- ----------- ---------- -----------------------
Percentage Percentage
Amount (3) Amount (3)
------- ---------- ----------- ---------- -------- ----------
CFFX, LLC (5) 139,864 * 6,000 139,864 0 N/A
c/o Compass Asset Management, LLC
30 South Wacker Drive, Suite 2707
Chicago, IL 60610
Ellsworth Convertible Growth and Income
Fund, Inc. 23,302 * 1,000 23,302 0 N/A
c/o Davis Dinsmore Management
65 Madison Avenue
Morristown, NJ 07960
Engineers Joint Pension Fund
c/o Nicholas Appelgate 7,457 * 320 7,457 0 N/A
600 West Broadway, 32nd Floor
San Diego, CA 92101
Fore Convertible Masterfund Limited
c/o Fore Advisors 104,898 * 4,500 104,898 0 N/A
280 Park Avenue, 43rd Floor
New York, NY 10017
Goldman Sachs & Co.(4)
295 Chipeta Way 137,533 * 5,900 137,533 0 N/A
Salt Lake City, UT 84108
Innovest Finanzdienstle
c/o Nicholas Appelgate 19,231 * 825 19,231 0 N/A
600 West Broadway, 32nd Floor
San Diego, CA 92101
KBC Financial Products USA Inc. (4)(5)
140 East 45th Street 11,073 * 475 11,077 0 N/A
2 Grand Central Tower, 42nd Floor
New York, NY 10017-3144
Lyxor/AM Investment Fund, Ltd.
c/o AM Investment Partners 48,952 * 2,100 48,952 0 N/A
350 Park Avenue, 4th Floor
New York, NY 10022
Nicholas Appelgate Capital Management
Convertible Fund 13,870 * 595 13,870 0 N/A
600 West Broadway, 32nd Floor
San Diego, CA 92101
----------
* Less than 1%
(1) Assumes conversion of all of the selling securityholder's debentures at a conversion rate of 23.3106 ADRs per each
$1,000 principal amount of debentures (rounded down to the nearest whole ADR).
(2) Includes, if applicable, conversion of all the selling securityholder's Teva Pharmaceutical Finance, LLC 1.50%
Convertible Senior Debentures due 2005 at a conversion rate of 23.1934 ADRs per each $1,000 principal amount of
debentures (rounded down to the nearest whole ADR). Includes, if applicable, conversion of all the selling
securityholder's Teva Pharmaceutical Finance, LLC 0.75% Convertible Senior Debentures due 2021 at a conversion rate of
23.3036 ADRs per each $1,000 principal amount of debentures (rounded down to the nearest whole ADR).
(3) Assumes that debentures held by other holders are not converted.
(4) The selling securityholder is a broker-dealer.
(5) The selling securityholder is an affiliate of a broker-dealer.
-3-
Principal
Amount of
Debentures
ADRs Beneficially Owned and
Owned Offered ADRs
Before Offering Hereby Offered ADRs Beneficially Owned
Name and Address of Selling Securityholder (1)(2) (in $1,000s) Hereby (1) After Offering (2)
-------------------------------------------- ------------------- ----------- ---------- -----------------------
Percentage Percentage
Amount (3) Amount (3)
------- ---------- ----------- ---------- -------- ----------
Physicians Life
c/o Nicholas Appelgate 4,079 * 175 4,079 0 N/A
600 West Broadway, 32nd Floor
San Diego, CA 92101
R2 Investments, LLC
c/o Amalgamated Gadget, L.P. 313,229 * 1,000 313,229 289,918 *
301 Commerce Street, Suite 2975
Fort Worth, TX 76102
RCG Halifax Master Fund, Ltd.
c/o Ramius Capital Group, LLC 17,483 * 750 17,483 0 N/A
666 Third Avenue, 26th Floor
New York, NY 10017
RCG Latitude Master Fund, Ltd.
c/o Ramius Capital Group, LLC 69,932 * 3,000 69,932 0 N/A
666 Third Avenue, 26th Floor
New York, NY 10017
RCG Multi Strategy A/C. LP
c/o Ramius Capital Group, LLC 46,621 * 2,000 46,621 0 N/A
666 Third Avenue, 26th Floor
New York, NY 10017
San Diego City Retirement
c/o Nicholas Appelgate 16,317 * 700 16,317 0 N/A
600 West Broadway, 32nd Floor
San Diego, CA 92101
San Diego County Convertible
c/o Nicholas Appelgate 35,432 * 1,520 35,432 0 N/A
600 West Broadway, 32nd Floor
San Diego, CA 92101
Southern Farm Bureau Life Insurance
c/o Froley Levy Investment Company Inc. 19,814 * 850 19,814 0 N/A
10900 Wilshire Boulevard, Suite 900
Los Angeles CA 90024
----------
* Less than 1%
(1) Assumes conversion of all of the selling securityholder's debentures at a conversion rate of 23.3106 ADRs per each
$1,000 principal amount of debentures (rounded down to the nearest whole ADR).
(2) Includes, if applicable, conversion of all the selling securityholder's Teva Pharmaceutical Finance, LLC 1.50%
Convertible Senior Debentures due 2005 at a conversion rate of 23.1934 ADRs per each $1,000 principal amount of
debentures (rounded down to the nearest whole ADR). Includes, if applicable, conversion of all the selling
securityholder's Teva Pharmaceutical Finance, LLC 0.75% Convertible Senior Debentures due 2021 at a conversion rate of
23.3036 ADRs per each $1,000 principal amount of debentures (rounded down to the nearest whole ADR).
(3) Assumes that debentures held by other holders are not converted.
(4) The selling securityholder is a broker-dealer.
(5) The selling securityholder is an affiliate of a broker-dealer.
-4-
Principal
Amount of
Debentures
ADRs Beneficially Owned and
Owned Offered ADRs
Before Offering Hereby Offered ADRs Beneficially Owned
Name and Address of Selling Securityholder (1)(2) (in $1,000s) Hereby (1) After Offering (2)
-------------------------------------------- ------------------- ----------- ---------- -----------------------
Percentage Percentage
Amount (3) Amount (3)
------- ---------- ----------- ---------- -------- ----------
Starvest Convertible Securities Fund
c/o Froley Levy Investment Company Inc. 6,993 * 300 6,993 0 N/A
10900 Wilshire Boulevard, Suite 900
Los Angeles CA 90024
Suttonbrook Capital Portfolio LP
c/o Suttonbrook Capital 233,106 * 10,000 233,106 0 N/A
654 Madison Avenue, Suite 1009
New York, NY 10021-8435
UBS AG London Branch
c/o Froley Levy Investment Company Inc. 307,747 * 13,202 307,747 0 N/A
10900 Wilshire Boulevard, Suite 900
Los Angeles CA 90024
US Bank FBO Benedictine Health Systems
c/o Froley Levy Investment Company Inc. 2,914 * 125 2,914 0 N/A
10900 Wilshire Boulevard, Suite 900
Los Angeles CA 90024
Wake Forest University
c/o Nicholas Appelgate 10,956 * 470 10,956 0 N/A
600 West Broadway, 32nd Floor
San Diego, CA 92101
Wyoming State Treasurer
c/o Nicholas Appelgate 19,115 * 820 19,115 0 N/A
600 West Broadway, 32nd Floor
San Diego, CA 92101
----------
* Less than 1%
(1) Assumes conversion of all of the selling securityholder's debentures at a conversion rate of 23.3106 ADRs per each
$1,000 principal amount of debentures (rounded down to the nearest whole ADR).
(2) Includes, if applicable, conversion of all the selling securityholder's Teva Pharmaceutical Finance, LLC 1.50%
Convertible Senior Debentures due 2005 at a conversion rate of 23.1934 ADRs per each $1,000 principal amount of
debentures (rounded down to the nearest whole ADR). Includes, if applicable, conversion of all the selling
securityholder's Teva Pharmaceutical Finance, LLC 0.75% Convertible Senior Debentures due 2021 at a conversion rate of
23.3036 ADRs per each $1,000 principal amount of debentures (rounded down to the nearest whole ADR).
(3) Assumes that debentures held by other holders are not converted.
(4) The selling securityholder is a broker-dealer.
(5) The selling securityholder is an affiliate of a broker-dealer.
-5-